Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors

Activity

Progress
1
Course Completed
Activity Information

Released: February 11, 2021

Expiration: February 10, 2022

Antonio Gonzalez-Martin
Antonio Gonzalez-Martin, MD, PhD
Ursula Matulonis
Ursula Matulonis, MD
Ignace Vergote
Ignace Vergote, MD, PhD